RÉMY COINTREAU : UBS remains Buy after trading update
In its research note, it points out that the group slightly beat expectations in terms of organic sales (-6.0% against a consensus of -6.7%), but that this was overshadowed by three to five months of inventories at the end of December and normalization in the US.
Rémy Cointreau looks well placed to deliver best-in-class sales and EBIT growth in 2023 and beyond", says the broker, who wonders whether short-term concerns are "overdone".
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction